EA199900687A1 - Соединения пиразина - Google Patents

Соединения пиразина

Info

Publication number
EA199900687A1
EA199900687A1 EA199900687A EA199900687A EA199900687A1 EA 199900687 A1 EA199900687 A1 EA 199900687A1 EA 199900687 A EA199900687 A EA 199900687A EA 199900687 A EA199900687 A EA 199900687A EA 199900687 A1 EA199900687 A1 EA 199900687A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkyl
substituted
hydrogen
group
halogen atom
Prior art date
Application number
EA199900687A
Other languages
English (en)
Other versions
EA002102B1 (ru
Inventor
Брайан Кокс
Малком Стюарт Ноббс
Джайта Панджэбхэй Ша
Дин Дейвид Эдни
Майкл Саймон Лофт
Original Assignee
Глаксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9704275.8A external-priority patent/GB9704275D0/en
Priority claimed from GBGB9708183.0A external-priority patent/GB9708183D0/en
Application filed by Глаксо Груп Лимитед filed Critical Глаксо Груп Лимитед
Publication of EA199900687A1 publication Critical patent/EA199900687A1/ru
Publication of EA002102B1 publication Critical patent/EA002102B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Abstract

Соединение формулы (I), где Rвыбран из группы, состоящей из фенила, замещенного одним или более чем одним атомом галогена, нафтила и нафтила, замещенного одним или более чем одним атомом галогена; Rвыбран из группы, состоящей из -NHи -NHC(=O)R; Rвыбран из группы, состоящей из -NRR, -NHC(=O)Rи водорода, Rвыбран из группы, состоящей из водорода, -Cалкила, -Cалкила, замещенного одним или более чем одним атомом галогена, -CN, -CHOH, -CHORи -CHS(O)R; где Rпредставляет собой Cалкил или Cциклоалкил, a Rи R, которые могут быть одинаковые или разные, выбраны из водорода и Cалкила, или вместе с атомом азота, к которому они присоединены, образуют 6-членный азотсодержащий гетероцикл, причем этот гетероцикл может быть далее замещен одним или более чем одним Cалкилом; Rвыбран из Cалкила или Cалкила, замещенного одним или более чем одним атомом галогена; x представляет собой целое число ноль, один или два; и его фармацевтически приемлемые производные; при условии, что Rне представляет собой (а), когда Rпредставляет собой -NH, а Rи Rоба представляют собой водород.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900687A 1997-03-01 1998-02-26 Производные аминоарилпиразинов и их применение EA002102B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9704275.8A GB9704275D0 (en) 1997-03-01 1997-03-01 Pharmacologically active compound
GBGB9708183.0A GB9708183D0 (en) 1997-04-23 1997-04-23 Pharmacologically active compound
PCT/EP1998/001077 WO1998038174A1 (en) 1997-03-01 1998-02-26 Pyrazine compounds

Publications (2)

Publication Number Publication Date
EA199900687A1 true EA199900687A1 (ru) 2000-04-24
EA002102B1 EA002102B1 (ru) 2001-12-24

Family

ID=26311097

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900687A EA002102B1 (ru) 1997-03-01 1998-02-26 Производные аминоарилпиразинов и их применение

Country Status (46)

Country Link
US (2) US6255307B1 (ru)
EP (1) EP0966448B1 (ru)
JP (1) JP3369189B2 (ru)
KR (1) KR100544263B1 (ru)
CN (1) CN1105111C (ru)
AP (1) AP9901632A0 (ru)
AR (1) AR011174A1 (ru)
AT (1) ATE251143T1 (ru)
AU (1) AU732915B2 (ru)
BG (1) BG103723A (ru)
BR (1) BR9807814B1 (ru)
CA (1) CA2282585C (ru)
CO (1) CO4950513A1 (ru)
CZ (1) CZ295618B6 (ru)
DE (1) DE69818643T2 (ru)
DK (1) DK0966448T3 (ru)
EA (1) EA002102B1 (ru)
EE (1) EE9900376A (ru)
ES (1) ES2205469T3 (ru)
GE (1) GEP20012555B (ru)
GT (1) GT199800046A (ru)
HK (1) HK1023116A1 (ru)
HN (2) HN1998000036A (ru)
HR (1) HRP980107A2 (ru)
HU (1) HU225852B1 (ru)
ID (1) ID22850A (ru)
IL (1) IL131293A (ru)
IS (1) IS5163A (ru)
JO (1) JO2035B1 (ru)
MA (1) MA26473A1 (ru)
MY (1) MY118612A (ru)
NO (1) NO313383B1 (ru)
NZ (1) NZ337121A (ru)
OA (1) OA11151A (ru)
PA (1) PA8448201A1 (ru)
PE (1) PE58299A1 (ru)
PL (1) PL192864B1 (ru)
PT (1) PT966448E (ru)
SI (1) SI0966448T1 (ru)
SK (1) SK117399A3 (ru)
SV (1) SV1998000029A (ru)
TR (1) TR199902082T2 (ru)
TW (1) TW513416B (ru)
UY (1) UY24911A1 (ru)
WO (1) WO1998038174A1 (ru)
YU (1) YU40799A (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
GB9818881D0 (en) 1998-08-28 1998-10-21 Glaxo Group Ltd Compounds
GB9907965D0 (en) * 1999-04-09 1999-06-02 Glaxo Group Ltd Medical use
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
WO2001060806A2 (en) * 2000-02-16 2001-08-23 Neurogen Corporation Substituted arylpyrazines
EP1500653A1 (en) * 2000-02-16 2005-01-26 Neurogen Corporation Substituted arylpyrazines
GB0010971D0 (en) * 2000-05-05 2000-06-28 Glaxo Group Ltd Process
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
SE0102439D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
SE0102438D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
EP1446387B1 (en) * 2001-11-21 2009-11-04 Pharmacia & Upjohn Company LLC Substituted aryl 1,4-pyrazine derivatives
US6992087B2 (en) 2001-11-21 2006-01-31 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
EP1458386B1 (en) * 2001-12-27 2007-04-18 Ortho-McNeil Pharmaceutical, Inc. Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
JP2005533014A (ja) 2002-04-26 2005-11-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 置換ピラジン誘導体
CA2496197A1 (en) 2002-08-20 2004-03-04 Neurogen Corporation 5-substituted-2-arylpyrazines as modulators of crf receptors
SE0203754D0 (sv) * 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
SE0203753D0 (sv) * 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
CA2514574A1 (en) 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Use of sodium channel modulators for treating gastrointestinal tract disorders
TW200510373A (en) * 2003-07-14 2005-03-16 Neurogen Corp Substituted quinolin-4-ylamine analogues
CA2595855C (en) 2005-01-25 2017-07-04 Synta Pharmaceuticals Corp. Pyrazine compounds for inflammation and immune-related uses
MX2007009923A (es) * 2005-02-15 2008-03-04 Jazz Pharmaceuticals Forma farmaceutica y metodo para liberacion sostenida de un compuesto de pirazina sustituido.
NL2000284C2 (nl) * 2005-11-04 2007-09-28 Pfizer Ltd Pyrazine-derivaten.
WO2007083239A1 (en) * 2006-01-23 2007-07-26 Pfizer Limited Pyridine derivatives as sodium channel modulators
CA2685952C (en) * 2007-05-03 2012-03-13 Pfizer Limited N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
GB0800741D0 (en) 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
FR3001151B1 (fr) 2013-01-21 2016-04-08 Pf Medicament Association d'un bloqueur de courant sodique lent et d'un inhibiteur du courant if sinusal et les compositions pharmarceutiques la contenant
JO3517B1 (ar) * 2014-01-17 2020-07-05 Novartis Ag ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
EA036446B1 (ru) 2016-06-14 2020-11-11 Новартис Аг Соединения и композиции для подавления активности shp2
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
CN108101857B (zh) * 2016-11-24 2021-09-03 韶远科技（上海)有限公司 制取2-氨基-3-溴-6-氯吡嗪的可放大工艺
CN107011273A (zh) * 2017-05-04 2017-08-04 无锡捷化医药科技有限公司 一种合成6‑碘‑3‑(2,3‑二氯苯基)吡嗪‑2‑胺的方法
CA3127871A1 (en) 2019-03-01 2020-09-10 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
CN115611700A (zh) * 2022-10-11 2023-01-17 辽宁东大光明化工科技有限责任公司 一种1-溴-2,5-二氯-3-氟苯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402958A (en) * 1981-11-19 1983-09-06 American Cyanamid Company Novel (substituted phenyl)-1,2,4-triazolo (4,3-A)pyrazines and novel 2-hydrazino-(substituted phenyl)pyrazine intermediates
DE3873812D1 (de) 1987-04-07 1992-09-24 Ciba Geigy Ag 3h-1,2,3-triazolo(4,5-d)pyrimidine.
JPH08238778A (ja) * 1995-03-07 1996-09-17 Brother Ind Ltd インク噴射装置の電極形成方法

Also Published As

Publication number Publication date
EE9900376A (et) 2000-04-17
HUP0001802A2 (hu) 2001-05-28
AP9901632A0 (en) 1999-09-30
MY118612A (en) 2004-12-31
HU225852B1 (en) 2007-11-28
IS5163A (is) 1999-08-24
ATE251143T1 (de) 2003-10-15
US6599905B2 (en) 2003-07-29
HUP0001802A3 (en) 2001-07-30
TR199902082T2 (xx) 2000-04-21
CN1105111C (zh) 2003-04-09
EP0966448A1 (en) 1999-12-29
NO313383B1 (no) 2002-09-23
AU6823798A (en) 1998-09-18
HN1998000036A (es) 1999-08-23
MA26473A1 (fr) 2004-12-20
EA002102B1 (ru) 2001-12-24
BG103723A (bg) 2001-05-31
AU732915B2 (en) 2001-05-03
SV1998000029A (es) 1998-12-11
CZ311199A3 (cs) 2000-02-16
CO4950513A1 (es) 2000-09-01
CN1253551A (zh) 2000-05-17
JP3369189B2 (ja) 2003-01-20
KR20000075859A (ko) 2000-12-26
PL192864B1 (pl) 2006-12-29
US20020169172A1 (en) 2002-11-14
PL335441A1 (en) 2000-04-25
CA2282585A1 (en) 1998-09-03
SK117399A3 (en) 2000-06-12
US6255307B1 (en) 2001-07-03
DE69818643T2 (de) 2004-10-07
JO2035B1 (en) 1999-05-15
DE69818643D1 (de) 2003-11-06
GEP20012555B (en) 2001-10-25
IL131293A0 (en) 2001-01-28
UY24911A1 (es) 2000-12-29
ES2205469T3 (es) 2004-05-01
AR011174A1 (es) 2000-08-02
EP0966448B1 (en) 2003-10-01
PA8448201A1 (es) 2000-05-24
TW513416B (en) 2002-12-11
IL131293A (en) 2003-07-31
WO1998038174A1 (en) 1998-09-03
HRP980107A2 (en) 1998-12-31
HK1023116A1 (en) 2000-09-01
OA11151A (en) 2003-04-22
DK0966448T3 (da) 2004-02-02
SI0966448T1 (en) 2004-04-30
JP2000511203A (ja) 2000-08-29
YU40799A (sh) 2001-09-28
BR9807814B1 (pt) 2009-01-13
CA2282585C (en) 2006-06-06
PT966448E (pt) 2004-02-27
NZ337121A (en) 2001-03-30
HN1999000019A (es) 1999-08-23
GT199800046A (es) 1999-08-20
BR9807814A (pt) 2000-02-22
KR100544263B1 (ko) 2006-01-23
NO994213L (no) 1999-10-29
CZ295618B6 (cs) 2005-09-14
NO994213D0 (no) 1999-08-31
ID22850A (id) 1999-12-09
PE58299A1 (es) 1999-06-23

Similar Documents

Publication Publication Date Title
EA199900687A1 (ru) Соединения пиразина
LU88621I2 (fr) Sandopril
DK1414302T3 (da) 7-aminotriazolopyrimidiner til bekæmpelse af skadelige svampe
GR1001619B (el) Παράγωγα ινδόλης.
IL105909A (en) Fungicidal compositions comprising indole derivatives, certain such novel compounds and their preparation
EA200000400A1 (ru) Галогензамещенные тетрациклические производные тетрагидрофурана
EA199900163A1 (ru) Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
EA199800759A1 (ru) 2-гетароилциклогексан-1,3-дионы
AP9600855A0 (en) Insecticidal n-(substituted phenyl) methyl) piperidines
EA199801013A1 (ru) Производные дистамицина, способ их получения и применение в качестве противоопухолевых и противовирусных агентов
EA200200729A1 (ru) Производные 4-фенил-1-пиперазинила, -пиперидинила и -тетрагидропиридила
CO4970802A1 (es) Compuesto bencimidazol-5 sustituido con estabilidad mejorada
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
ATE209201T1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren
DE69416683T2 (de) Benzolactam-derivate
EA200200523A1 (ru) Новые разветвленные замещенные аминопроизводные 3-амино-1-фенил-1h[1,2,4]триазола, способы их получения и содержащие их фармацевтические композиции
DK0579059T3 (da) Pyridazinonderivater og fremgangsmåder til fremstilling af samme
DE69813554D1 (de) Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer
KR970069989A (ko) 피리딘-2,3-디카르복실산 디아미드 유도체 및 유효성분으로 상기 유도체를 함유하는 제초제
AU576347B2 (en) 3-phenyl-2-propeneamine derivatives
TR199901301T2 (xx) Yeni eritromisin t�revleri ve bunlar�n haz�rlanma y�ntemi.
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
ATE151750T1 (de) 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
EA199800083A1 (ru) Производные 1,3-оксазин-4-она в качестве гербицидов

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU